Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
Current Portion of Long-Term Debt
Prestige Consumer Healthcare Inc
Current Portion of Long-Term Debt Peer Comparison
Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Current Portion of Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Current Portion of Long-Term Debt
$2.2m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-27%
|
|
Johnson & Johnson
NYSE:JNJ
|
Current Portion of Long-Term Debt
$2.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
13%
|
CAGR 10-Years
-5%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Current Portion of Long-Term Debt
$2.9B
|
CAGR 3-Years
24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
26%
|
|
Pfizer Inc
NYSE:PFE
|
Current Portion of Long-Term Debt
$2.3B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-13%
|
|
Merck & Co Inc
NYSE:MRK
|
Current Portion of Long-Term Debt
$3.1B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-10%
|
|
Eli Lilly and Co
NYSE:LLY
|
Current Portion of Long-Term Debt
$1.7B
|
CAGR 3-Years
591%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
68%
|
See Also
What is Prestige Consumer Healthcare Inc's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
2.2m
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Current Portion of Long-Term Debt amounts to 2.2m USD.
What is Prestige Consumer Healthcare Inc's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
-27%
Over the last year, the Current Portion of Long-Term Debt growth was -22%. The average annual Current Portion of Long-Term Debt growth rates for Prestige Consumer Healthcare Inc have been -6% over the past three years , and -27% over the past ten years .